Amyotrophic Lateral Sclerosis: Pathophysiological Mechanisms and Treatment Strategies (Part 2)

Area of Science:

• Neuroscience
• Neurology
• Pathology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
• ALS is characterized by motor neuron damage, resulting in severe muscle weakness and eventual mortality.
• Key pathogenetic mechanisms include glutamate-mediated excitotoxicity and oxidative stress.

Purpose of the Study:

• To review recent evidence on the molecular mechanisms of excitotoxicity and oxidative stress in ALS.
• To explore therapeutic strategies targeting these molecular mechanisms.
• To highlight antiglutamatergic and antioxidant drugs for ALS pathogenetic therapy.

Main Methods:

• Literature review of recent evidence.
• Analysis of molecular mechanisms in ALS pathogenesis.
• Evaluation of therapeutic strategies and drug classes.

Main Results:

• Significant advancements in understanding ALS pathogenetic links.
• Evidence supporting the roles of excitotoxicity and oxidative stress.
• Identification of antiglutamatergic and antioxidant drugs as potential therapies.

Conclusions:

• Excitotoxicity and oxidative stress are critical in ALS pathogenesis.
• Modulating these pathways offers promising therapeutic avenues.
• Antiglutamatergic and antioxidant drugs represent key strategies for ALS treatment.